
Mark Samuels on Open Innovation in Pharma
The Pharma Times Online website posted an interview with Mark Samuels, chief business and strategy officer of the new Medicines Discovery Catapult, on the role of open innovation in big pharma: “I think collaborative research is increasingly important. Benefits of open innovation include access to knowledge outside the firm, as well as being able
Comments Off on Mark Samuels on Open Innovation in Pharma • Read this story »